Collecting PRO Data In Cancer Trials: Bringing The Patient Perspective In Oncology Clinical Research
Oncology clinical trials, despite constituting a significant portion of the research pipeline, have historically struggled with lower productivity rates compared to other therapeutic areas. The complexities inherent in cancer treatment, from patient heterogeneity to multiple endpoints, have contributed to this challenge. As the industry seeks innovative approaches to streamline these trials, a growing recognition of the patient's perspective is emerging.
Patient Reported Outcomes (PROs), capturing the symptoms and feelings experienced by patients, have long been underutilized in oncology research. While traditionally considered exploratory, there is a mounting body of evidence demonstrating the critical role PROs play in assessing treatment benefits and risks. By incorporating PROs into clinical trials, researchers can gain invaluable insights into a patient’s experience, leading to more accurate safety profiles, improved endpoint selection, and ultimately, faster drug development.
With a robust framework for PRO data collection now in place, including validated scales and regulatory support, the time is ripe to fully harness the power of the patient's voice in oncology clinical research.
This article will delve into the importance of PROs in oncology trials, explore the benefits of incorporating PRO data, and discuss the practical steps involved in implementing effective PRO collection strategies.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.